Ophthalmology · Mount Vernon, NY
NPI
1174568299
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
153 Stevens Ave, Suite 6
Mount Vernon, NY, 10550
Phone (914) 667-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$160K
2,310 services
Medicare patients, 2024
400
Average age 77
Drug cost, 2024
$1.6M
5,286 prescriptions
Company payments, 2025
$619
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amir Yamani was code 92014 (ophthalmological e&m), 636 times for 363 patients. In total Amir Yamani billed 2,310 services in 34 codes, and Medicare paid $160K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 636 | 363 | $103.46 | $66K |
| 92020 Ophthalmological E&M | Office | 317 | 308 | $22.40 | $7,100 |
| 92250 Angiography | Office | 264 | 257 | $29.02 | $7,661 |
| 92273 Test - Miscellaneous | Office | 226 | 183 | $111.00 | $25K |
| 92083 Vision, Hearing, and Speech Services | Office | 155 | 150 | $51.79 | $8,028 |
| 92133 Computerized Ophthalmic Imaging | Office | 155 | 155 | $29.06 | $4,504 |
| 92202 Ophthalmological E&M | Office | 132 | 129 | $12.71 | $1,678 |
| 92134 Computerized Ophthalmic Imaging | Office | 53 | 53 | $34.32 | $1,819 |
| 92286 Standard X-ray | Office | 51 | 51 | $30.27 | $1,544 |
| 92004 Ophthalmological E&M | Office | 45 | 45 | $110.49 | $4,972 |
| 76513 Ultrasound - Nonspecific | Office | 43 | 43 | $64.48 | $2,773 |
| 92012 Ophthalmological E&M | Office | 34 | 25 | $78.51 | $2,669 |
| 99214 Office E&M - Established | Office | 31 | 31 | $40.29 | $1,249 |
| 92136 Ultrasound - Nonspecific | Office | 26 | 13 | $21.41 | $557 |
| 76512 Ultrasound - Nonspecific | Office | 15 | 11 | $33.61 | $504 |
By year: 2022 $148K for 2,200 services; 2023 $150K for 2,177 services; 2024 $160K for 2,310 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 36 | 18 | $22.03 | $793 |
Medicare prescription drug claims, 2024
In 2024, the drug Amir Yamani prescribed most often to Medicare patients was Latanoprost, with 769 prescriptions and refills. In total Amir Yamani wrote 5,286 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 769 | 1,107 | 131 | $5,091 |
| Azelastine Hcl Generic | 558 | 933 | 227 | $12K |
| Miebo Perfluorohexyloctane/Pf | 366 | 418 | 94 | $300K |
| Restasis Cyclosporine | 343 | 602 | 85 | $366K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 284 | 499 | 58 | $3,273 |
| Prednisolone Acetate Generic | 234 | 296 | 110 | $12K |
| Eysuvis Loteprednol Etabonate | 189 | 221 | 43 | $112K |
| Zerviate Cetirizine Hcl | 173 | 175 | 29 | $55K |
| Diclofenac Sodium Generic | 163 | 190 | 77 | $1,608 |
| Xiidra Lifitegrast | 154 | 171 | 38 | $114K |
| Lumigan Bimatoprost | 147 | 321 | 50 | $85K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 129 | 143 | 25 | $50K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 128 | 137 | 88 | $1,105 |
| Timolol Maleate Generic | 120 | 213 | 25 | $3,862 |
| Tyrvaya Varenicline Tartrate | 107 | 110 | 30 | $67K |
Brand drugs: 2,906 claims; generic drugs: 2,380 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amir Yamani $619 ($619 in general payments such as food, travel and fees) from 6 companies. The largest payer was Bausch & Lomb Americas Inc. with $220.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 12 | $220 |
| Harrow Eye, LLC | 15 | $190 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 4 | $75.06 |
| Alcon Vision LLC ALC | 4 | $72.83 |
| Amgen Inc. AMGN | 2 | $47.29 |
| Oyster Point Pharma, Inc. | 1 | $14.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.